Symposium on Methods in Renal Research

Kidney International (1986) 30, 264–279; doi:10.1038/ki.1986.178

Experimental strategies for the study of cellular immunity in renal disease

Eric G Neilson1, Michael D Clayman1, Thomas Haverty1, Carolyn J Kelly1 and Richard Mann1

1Renal–Electrolyte Section, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Correspondence: Eric G Neilson MD, Renal-Electrolyte Section, 860 Gates Pavilion, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, Pennsylvania 19104.

Received 26 February 1986.

Top

References

  1. Neilson EG, Zakheim B: T cell regulation, anti-idiotypic immunity, and the nephritogenic immune response. Kidney Int 24:289–302, 1983
  2. Sercarz E: T cell recognition from an immunosemiotic perspective, in Regulation of the Immune System, edited by Cantor H, Chess L, Sercarz E, New York, Alan R Liss, 1984, pp. 651–662
  3. Benacerraf B, Germain RN: The immune response genes of the major histocompatibility complex. Immunol Rev 38:70–119, 1978 | Article | PubMed | ChemPort |
  4. Steinmetz M, Hood L: Genes of the major histocompatibility complex in mouse and man. Science 222:727–733, 1983 | PubMed | ISI | ChemPort |
  5. Bach FH: The HLA class II genes and products: The HLA-D region. Immunol Today 6:89–94, 1985
  6. Fathman CG, Frelinger JG: T-lymphocyte clones. Ann Rev Immunol 1:633–656, 1983
  7. Zinkernagel RM, Doherty PC: Immunologic surveillance against altered self components by sensitized T lymphocytes in lymphocytic choriomeningitis. Nature 251:547–548, 1974 | Article | PubMed | ISI | ChemPort |
  8. Schwartz RH: T lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Ann Rev Immunol 3:237–263, 1985
  9. Zinkernagel RM, Doherty PC: MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness. Adv Immunol 27:51–177, 1979 | PubMed | ChemPort |
  10. Taniguchi M, Miller JFAP: Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med 146:1450–1454, 1977 | Article | PubMed | ISI | ChemPort |
  11. Sherr DH, Dorf ME: Hapten–specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XIII. Characterization of a third T cell population involved in suppression of in vitro PFC responses. J Immunol 128:1261–1266, 1982
  12. Sell S: Development of restrictions in the expression of immunoglobulin specificities by lymphoid cells. Transplant Rev 5:22 44, 1970
  13. Patten P, Yokota T, Rothbard J, Chien Y, Arai K, Davis MM: Structure, expression and divergence of T-cell receptor beta-chain variable regions. Nature 312:40–46, 1984 | Article | PubMed | ISI | ChemPort |
  14. Yano A, Schwartz RH, Paul WE: Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompability complex. J Exp Med 146:828–843, 1977 | Article | PubMed | ISI | ChemPort |
  15. Rosenthal AS, Shevach EM: Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J Exp Med 138:1194–1212, 1973 | Article | PubMed | ISI | ChemPort |
  16. Katz DH, Graves M, Dorf ME, Dimuzio H, Benacerraf B: Cell interactions between histoincompatible t and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex. J Exp Med 141:263–268, 1975 | Article | PubMed | ISI | ChemPort |
  17. Swain S: T cell subsets and the recognition of the MHC Class. Immunol Rev 74:129–142, 1983 | Article | PubMed | ISI | ChemPort |
  18. Spits H, Yssel H, Voordouw A, DeVries JE: The role of T8 in the cytotoxic activity of cloned cytotoxic T lymphocyte lines specific for Class II and Class I major histocompatibility complex antigens. J Immunol 134:2294–2298, 1985
  19. Rajewsky K, Takemori T: Genetics, expression, and function of idiotypes. Ann Immunol 1:569–608, 1983
  20. Owen FL: T cell alloantigens encoded by the IgT-C region of chromosome 12 in the mouse. Adv Immunol 34:1–30, 1983
  21. Hayes CE, Klyczek KK, Krum DP, Whitcomb RM, Hullett DA, Cantor H: Chromosome 4 Jt gene controls murine T cells surface I-J expression. Science 223:559–563, 1984 | PubMed | ISI | ChemPort |
  22. Ford WL: Lymphocyte migration and immune response. Prog Allergy 19:1–59, 1975 | PubMed | ISI | ChemPort |
  23. Ortaldo JR, Herberman RB: Hetergeneity of natural killer cells. Ann Rev Med 2:359–394, 1984
  24. Stevens SK, Weissman IL, Butcher EC: Differences in the migration of B and T lymphocytes: Organ–selective localization in vivo and the role of lymphocyte–endothelial cell recognition. J Immunol 128:844–851, 1982 | PubMed | ISI | ChemPort |
  25. Davidson W, Parish CR: A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Meth 7:291–300, 1975
  26. Reinherz EL, Schlossman SF: The differentiation and function of human T lymphocytes. Cell 19:821–827, 1980 | Article | PubMed | ISI | ChemPort |
  27. Meuer SC, Schlossman SF, Reinherz EL: Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci USA 79:4395–4399, 1982 | Article | PubMed | ChemPort |
  28. Acuto O, Reinherz EL: The human T-cell receptor: Structure and function. N Engl J Med 312:1100–1110, 1985
  29. Ledbetter JA, Rouse RV, Spedding–Micklem H, Herzenberg LA: T-cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens: Two–parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med 152:280–295, 1980 | Article | PubMed | ISI | ChemPort |
  30. Walker ID, Hogarth PM, Murray BJ, Lovering KE, Classon BJ, Chambers GW, McKenzie IFC: Ly antigens associated with T cell recognition and effector function. Immunol Rev 82:47–77, 1984 | PubMed | ChemPort |
  31. Swain SL: Significance of Lyt phenotypes: Lyt 2 antibodies block activities of T cells that recognize class I major histocompatibility complex antigens regardless of their function. Proc Natl Acad Sci USA 78:7101–7105, 1981 | PubMed | ChemPort |
  32. Swain SL, Dialynas DP, Fitch FW, English M: Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J Immunol 132:1118–1123, 1984
  33. Dialynas DP, Wilde DB, Marrack P, Pierres A, Wall KA, Havran W, Otten G, Luken MR, Pierres M, Kappler J, Fitch FW: Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: Expression of L3T4a by functional T cell clones appears to correlate primarily with Class II MHC antigen-reactivity. Immunol Rev 74:29–56, 1983 | Article | PubMed | ISI | ChemPort |
  34. Mason DW, Arthur RP, Dallman MJ, Green JR, Spickett GP, Thomas ML: Function of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev 74:57–82, 1983
  35. Koo GC, Jacobson JB, Hammerling GJ, Hammerling U: Antigenic profile of murine natural killer cells. J Immunol 125:1003–1006, 1980
  36. Bruce J, Symington FW, McKern TJ, Sprent J: A monoclonal antibody descriminating between subsets of T and B cells. J Immunol 127:2496–2501, 1981 | PubMed | ISI | ChemPort |
  37. Wofsy D, Seaman WE: Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161:378–391, 1985 | Article | PubMed | ISI | ChemPort |
  38. Adelman NE, Watling DL, McDevitt HO: Treatment of (NZB times NZW)F1 disease with anti-I-A monoclonal antibody. J Exp Med 158:1350–1355, 1983 | PubMed |
  39. Cowing C, Schwartz BD, Dickler HB: Macrophage la antigens I. Macrophage population differ in their expression of la antigens. J Immunol 120:378–384, 1978
  40. Julius MH, Simpson E, Herzenberg LA: A rapid method for the isolation of functional thymus–derived murine lymphocytes. Eur J Immunol 3:645–649, 1973 | PubMed | ISI | ChemPort |
  41. Mage MG, McHugh LL, Rothstein TL: Mouse lymphocytes with and without surface immunoglobulins: Preparative scale separations in polystyrene tissue culture dishes coated with specificity purified anti-immunoglobulin. J Immunol Meth 15:47–56, 1977
  42. Wysocki LJ, Sato VL: Panning for lymphocytes: a method for cell selection. Proc Natl Acad Sci USA 75:2844–2848, 1978 | Article | PubMed | ChemPort |
  43. Luken MA, Herzenberg LA: Analysis of cell populations with a fluorescence–activated sorter. Ann NY Acad Sci 254:163–171, 1975
  44. Morgan DA, Ruscetti FW, Gallo RC: Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007–1008, 1976 | Article | PubMed | ISI | ChemPort |
  45. Gillis S, Smith KA: Long–term culture of tumour–specific cytotoxic T cells. Nature 268:154–156, 1977 | Article | PubMed | ISI | ChemPort |
  46. Watson J, Gillis S, Marbrook J, Mochizwki D, Smith KA: Biochemical and biological characterization of lymphocyte regulatory molecules I. Purification of a class of murine lymphokines. J Exp Med 150:849–861, 1979 | Article | PubMed | ISI | ChemPort |
  47. Gillis S, Watson J: Biochemical and biological characterization of lymphocyte regulatory molecules V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med 152:1709–1719, 1980 | Article | PubMed | ISI | ChemPort |
  48. Gillis S, Scheid N, Watson J: Biochemical and biological characterization of lymphocyte regulatory molecules III. The isolation and phenotypic characterization of interleukin-2 producing T cell lymphomas. J Immunol 125:2570–2578, 1980
  49. Spiess PJ, Rosenberg SA: A simplified method for the production of immune T-cell growth factor free of lectin. J Immunol Meth 12:213–222, 1981
  50. Rabin H, Hopkins RF, Ruscetti FW, Neubauer RH, Brown RL, Kawakami RG: Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol 127:1852–1855, 1981 | PubMed | ChemPort |
  51. Lanier LL, Benike CJ, Phillips JH, Engleman EG: Recombinant interleukin 2 enhanced natural killer cell–mediated cytotoxicity in human lymphocyte subpopulations expressing the LEU 7 and LEU 11 antigens. J Immunol 134:794–801, 1985 | PubMed | ChemPort |
  52. Gillis S, Ferm MM, Lu W, Smith KA: T cell growth factor: Parameters of production and quantitative microassay for activity. J Immunol 120:2027–2032, 1978 | PubMed | ISI | ChemPort |
  53. Kappler JW, Skidmore B, White J, Marrack P: Antigen–inducible H-2 restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med 153:1198–1214, 1981 | Article | PubMed | ISI | ChemPort |
  54. Hengartner H, Fathman CG: Clones of alloreactive T. cells. I. A unique homozygons MLR-stimulating determinant present on B6 stimulators. Immunogenetics 10:175–184, 1980
  55. Bach FH, Inouye H, Hank JA, Alfer BJ: Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity. Nature 281:307–309, 1979 | Article | PubMed | ISI | ChemPort |
  56. Glasebrook AL, Fitch FW: Alloreactive cloned T cell lines. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med 151:876–895, 1980 | Article | PubMed | ISI | ChemPort |
  57. Webb SR, Hu Li J, MacNeil I, Marrack P, Sprent J, Wilson DB: T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes. J Exp Med 161:269–274, 1985 | Article | PubMed | ChemPort |
  58. Webb SR, Molnar–Kimber K, Bruce J, Sprent J, Wilson DB: T cell clones with dual specificity for Mis and various major histocompatibility complex determinants. J Exp Med 154:1970–1974, 1981 | Article | PubMed | ISI | ChemPort |
  59. Ben–Nun H, Cohen IR: Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells. J Immunol 129:303–308, 1982
  60. Kimoto M, Fathman CG: Antigen–reactive T cell clones I. Transcomplementing hybrid I-A region gene products function effectively in antigen presentation. J Exp Med 152:759–770, 1980 | Article | PubMed | ISI | ChemPort |
  61. Schmidt C, Cogne M, Agrapart M, Ballet JJ: Major histocompatibility complex restriction of tetanus toxoid–specific human T lymphocyte clones. Eur J Immunol 14:1131–1136, 1984
  62. Sredni B, Tse HY, Chen C, Schwartz RH: Antigen–specific clones of proliferating T lymphocytes L Methodology, specificity, and MHC restriction. J Immunol 126:341–347, 1981
  63. Trotter J, Sriram S, Rasenti L, Jen Chou CH, Fritz RB, Steinman L: Characterization of T cell lines and clones from SJL and (Balb/c times SJL)F1 mice specific for myelin basic protein. J Immunol 134:2322–2327, 1985
  64. Mann R, Zakheim B, Ciayman M, McCafferty E, Michaud L, Neilson EG: Murine interstitial nephritis. IV. Long–term cultured L3T4+ T cell lines transfer delayed expression of disease as I-A restricted inducers of the effector T cell repertoire. J Immunol 135:286–293, 1985 | PubMed | ISI | ChemPort |
  65. Levich JD, Weigle WO, Parks DE: Long–term suppressor cell lines. I. Demonstration of suppressive function. Eur J Immunol 14:1073–1079, 1984
  66. Levich JD, Weigle WO, Parks DE: Long–term suppressor cell lines. II. Suppressor–target interactions. Eur J Immunol 14:1080–1084, 1984
  67. Nabel G, Fresno M, Chessman A, Cantor H: Use of cloned populations of mouse lymphocytes to analyze cellular differentiation. Cell 23:19–28, 1981 | Article | PubMed | ISI | ChemPort |
  68. Fresno M, Nabel G, McVay–Boudreau L, Furthmayer H, Cantor H: Antigen–specific T lymphocyte clones I. Characterization of a T lymphocyte clone expressing antigen–specific suppressive activity. J Exp Med 153:1246–1259, 1981 | Article | PubMed | ISI | ChemPort |
  69. Morimoto C, Reinherz EL, Todd RF, Distaso JA, Schlossman SF: Generation of antigen–specific suppressor cells in vitro in man. J Immunol 131:1209–1213, 1983
  70. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495 497, 1975 | Article | PubMed | ISI | ChemPort |
  71. Taniguchi M, Saito T, Tada T: Antigen–specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma. Nature 278:555–558, 1979 | Article | PubMed | ISI | ChemPort |
  72. Hammerling GJ: T lymphocyte tissue culture lines produced by cell hybridization. Eur J Immunol 7:743–746, 1977
  73. Nabholz M, Cianfriglia M, Acuto O, Conzelmann A, Haas W, Von Boehmer H, MacDonald HR, Pohlit H, Johnson JP: Cytolytically active murine T cell hybrids. Nature 287:437–440, 1980 | Article | PubMed | ISI | ChemPort |
  74. Lonai P, Puri J, Hammerling GJ: H-2 restricted antigen binding by a hybridoma clone which produces specific helper factor. Proc Natl Acad Sci USA 78:549–553, 1981
  75. Taniguchi M, Miller JF: Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T-cells and a T lymphoma cell line. J Exp Med 148:373–382, 1978 | Article | PubMed | ISI | ChemPort |
  76. Minami M, Okuda K, Furusawa S, Benacerraf B, Dorf ME: Analysis of T cell hybridomas. I. Characterization of H-2 and Igh restricted monoclonal suppressor factors. J Exp Med 154:1370–1402, 1981
  77. Marrack P, Kappler J: Use of somatic cell genetics to study chromosomes contributing to antigen plus I region recognition by T cell hybridomas. J Exp Med 157:404–418, 1983
  78. Kindred B, Shreffler DC: H-2 dependence of cooperation between T and B cells in vivo. J Immunol 109:940–943, 1972 | PubMed | ChemPort |
  79. Katz DH, Hamaoka T, Benacerraf B: Cell interaction between histocompatible T and B lymphocytes. II. Failure of physiologic cooperative interaction between T and B lymphocytes from allogeneic donor strains in humoral response to hapten–carrier conjugates. J Exp Med 137:1405–1418, 1973 | Article | PubMed | ISI | ChemPort |
  80. Brunswick M, Lake P: Obligatory role of gamma interferon in T cell–replacing factor–dependent, antigen–specific murine B cell responses. J Exp Med 161:953–971, 1985
  81. Lanzavecchia A: Antigen–specific interaction between T and B cells. Nature 314:537–538, 1985 | Article | PubMed | ISI | ChemPort |
  82. Feldmann N, Basten A: Cell interactions in the immune response in vitro. III. Specific cooperation across a cell impermeable membrane. J Exp Med 136:49–67, 1972
  83. Taussing MJ: Antigen–specific helper T cell factor and its acceptor, in Immunological Methods, edited by Lefkovitts I, Pernis B, New York, Academic Press, 1979, p. 317
  84. Shiozawa C, Sonir S, Singh B, Diener E: Antigen–specific T cell derived helper factor, in Biochemical Characterization of Eymphokines, edited by DeWeck AL, Kristensen F, Landy M, New York, Academic Press, 1980, p. 557
  85. Sawada S, Dauphinee MJ, Talal N: Antigen–specific factors produced by carrier primed New Zealand Black mice. J Immunol 124:1263–1266, 1980
  86. Howie S, Parish CR, David CS, McKenzie IPC, Maurer PH, Feldmann M: Serological analysis of antigen–specific helper factors specific for poly-L-(Tyr, Glu)-poly-DL-ALA-poly-L-Lys ((T,G)-A-L) and LGlu60-LaLA30-Ltyr10(GAT). Eur J Immunol 9:501–506, 1979
  87. Erb P, Feldmann M: The role of macrophages in the generation of T-helper cells. I. The requirement for macrophages in helper cell induction and characteristics of the macrophage T cell interaction. Cell Immunol 19:356–367, 1975 | Article | PubMed | ChemPort |
  88. McDaugal JS, Gordon DS: Generation of T helper cells in vitro. I. Cellular and antigen requirements. J Exp Med 145:676–692, 1977
  89. Eshhar Z, Woks T, Zinger H, Moses E: T-cell hybridomas producing antigen–specific factors express heavy chain–variable–region determinants. Curr Topics Microbiol Immunol 100:103–109, 1982
  90. Webb DR, Kapp JA, Pierce CW: The biochemistry of antigen–specific T-cell factors. Ann Rev Immunol 1:423 438, 1983
  91. Green DR, Flood PM, Gershon RK: Immunoregulatory T-cell pathways. Ann Rev Immunol 1:439–463, 1983
  92. Dorf ME, Benacerraf B: Suppressor cells and immunoregulations. Ann Rev Immunol 2:127–158, 1984 | Article | ChemPort |
  93. Dorf ME, Minami M, Usui M, Aoki I: The NP suppressor cell cascade, in Progress in Immunology, vol 5, edited by Tada T, New York Academic, 1984
  94. Weinberger JA, Germain RN, Ju ST, Green MI, Benacerraf B, Dorf ME: Hapten specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl II. Demonstration of idiotypic determinants or suppressor T cells. J Exp Med 150:761–776, 1979 | Article | ISI | ChemPort |
  95. Lewis GK, Goodman JW: Purification of functional determinant specific idiotype–bearing murine T cells. J Exp Med 148:915–924, 1978
  96. Taniguchi M, Miller JFAP: Specific suppressor factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T tymphoma cell line. J Exp Med 148:373–382, 1978 | Article | PubMed | ISI | ChemPort |
  97. Benacerraf B, Greene MI, Sy MS, Dorf ME: Suppressor T cell circuits. Ann NY Acad Sci 392:300–308, 1982
  98. Sunday ME, Stadecker MJ, Wright JA, Aoki I, Dorf ME: Induction of immune response by schistosoma granuloma macrophages. J Immunol 130:2413–2417, 1983
  99. Nakamura RM, Tanaka H, Toxunaga T: In vitro induction of suppressor T cells in delayed–type hypersensitivity to BCG and an essential role of I-J positive accessory cells. Immunol Lett 4:295–299, 1982
  100. Lowy A, Tominaga A, Drebin JA, Takaoki M, Benacerraf B, Greene MI: Identification of an I-J+ antigen–presenting cell required for third order suppressor cell activation. J Exp Med 157:353–358, 1983 | Article | PubMed | ISI | ChemPort |
  101. Kelly CJ, Silvers W, Neilson E: A tubular antigen–specific suppressor T cell in BN rats mediated ontologie tolerance to autologous tubular antigen. (abstract) Kidney Int 27:215A, 1985
  102. Neilson EG, McCafferty E, Phillips SM, Clayman MD, Kelly CJ: Antiidiotypic immunity in interstitial nephritis. II. Rats developing anti-tubular basement membrane disease fail to make an antoidiotypic regulatory response: the modulatory role of an RT7.1 +, OX8- suppressor T cell mechanism. J Exp Med 159:1009–1026, 1984
  103. Cantor H, McVoy–Boudreau L, Hughenberger J, Naidorf K, Shen FW, Gershon RK: Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: Absence in NZB mice. J Exp Med 147:1117–1125, 1979
  104. Bakker WW, Kooistra K, Vos JTWM, Hoedemaeker PJ: Suppressor cells directed against self-receptors in experimental autologous glomerulonephritis detected by MIF assays. 12th Leukocyte Culture Conference, New York, Academic Press, 1979, pp. 695–699
  105. Cohen PL, Eisenberg RA: Anti-idiotypic antibodies to the Coombs antibody in NZB F1 mice. J Exp Med 156:173–180, 1982
  106. Bowman C, Mason DW, Pusey CD, Lockwood CM: Autoreg-ulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat I. A role for T suppressor cells. Eur J Immunol 114:464–470, 1984
  107. Chalopin JM, Lockwood CM: Autoregulation of autoantibody synthesis in mercuric chloride nephritis in Brown Norway rats. II. Presence of antigen–augmentable plaque–forming cells in the spleen is associated with humoral factors behaving as auto-anti-idiotypic antibodies. Eur J Immunol 14:470–475, 1984
  108. Egido J, Sancho J, Blasco R, Rivera F, Hernando L: Immunopathogenetic aspects of IgA nephropathy. Adv Nephrol 12:103–137, 1983
  109. Krakauer RS, Waldmann TA, Strober W: Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med 144:662–673, 1976 | Article |
  110. Andersson LC, Aguet M, Wight E, Andersson R, Binz H, Wigzell H: Induction of specific immune unresponsiveness using purified mixed leukocyte culture–activated T lymphoblasts as autoimmunogen. I. Demonstration of general validity as to species and histocompatibility barriers. J Exp Med 146:1124–1137, 1977 | Article | PubMed | ISI | ChemPort |
  111. Neilson EG, Phillips SM: Suppression of interstitial nephritis by auto-antiidiotypic immunity. J Exp Med 155:179–189, 1982
  112. Harmon WE, Grupe WE, Parkman R: Control of autologous immune complex nephritis. I. Suppression of the disease in the presence of T cell sensitization. J Immunol 124:1034–1038, 1980
  113. Litwin A, Bash JA, Adams LE, Donovan RJ, Hess EV: Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells. J Immunol 122:1029–1033, 1979
  114. Neilson EG, McCafferty E, Mann R, Michaud L, Clayman M: Tubular antigen–derivatized cells induce a disease–protective antigen–specific and idiotype–specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis. J Exp Med 162:215–230, 1985
  115. Greene MI, Nelles MJ, Nisonoff A: Regulation of immunity to the azobenzenearsonate hapten. Adv Immunol 32:253–299, 1982 | PubMed | ChemPort |
  116. Tada T, Takemori T: Selective roles of thymus–derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier–primed T cells on hapten–specific IgM and IgG antibody responses. J Exp Med 140:239–252, 1974 | Article | PubMed | ISI | ChemPort |
  117. Kontiainen S, Feldman M: Suppressor cell induction in vitro. I. Kinetics of induction of antigen–specific suppressor cells. Eur J Immunol 6:296–301, 1976
  118. Goldsby RA, Osborne BA, Simpson E, Herzenberg LA: Hybrid cell lines with T cell characteristics. Nature 267:707–708, 1977 | Article | PubMed | ISI | ChemPort |
  119. Germain RN, Benacerraf B: Helper and suppressor T cell factors. Springer Semin Immunopathol 3:93–127, 1980
  120. Taussig MJ: Antigen–specific T-cell factors. Immunology 41:759–787, 1980
  121. Altman A, Katz DH: Production and isolation of helper and suppressor factors. J Immunol Meth 38:9–41, 1980
  122. Tada T: Help, suppression, and specific factors, in Fundamental Immunology, edited by Paul WE, New York, Raven Press, 1984, pp. 481–517
  123. Pierres M, Germain RN: Antigen–specific T cell mediated suppression IV. Rol of macrophages in generation of GAT-specific suppressor T cells in responder mouse strains. J Immunol 121:1306–1314, 1978
  124. Germain RN, Benacerraf B: A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Stand J Immunol 13:1–10, 1981
  125. Flood PM, Lowy A, Tominaga A, Clive B, Greene MI, Gershon RK: Igh variable region–restricted T cell interactions. Genetic restriction of an antigen–specific suppressor inducer factor is imparted by an I-J+ antigen-nonspecific molecule. J Exp Med 158:1938–1947, 1983
  126. Rosenthal AS, Sherach EM: Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement histocompatible macrophages and lymphocytes. J Exp Med 138:1194–1212, 1973 | Article | PubMed | ISI | ChemPort |
  127. Yano A, Schwartz RH, Paul WE: Antigen presentation in the murine T lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex. J Exp Med 146:828–843, 1977 | Article | PubMed | ISI | ChemPort |
  128. Cantor H, Boyse EA: Functional subclasses of T lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T cell subclasses is a differentiative process independent of antigen. J Exp Med 141:1376–1389, 1975 | Article | PubMed | ISI | ChemPort |
  129. Rosenstreich DL, Farrar JJ, Dougherty S: Absolute macrophage dependency of T lymphocyte activation by mitogens. J Immunol 116:131–139, 1976 | PubMed | ChemPort |
  130. Larsson E, Iscove NN, Coutinno A: Two distinct factors are required for the induction of T cell growth. Nature 283:664–666, 1980 | Article | PubMed | ISI | ChemPort |
  131. Smith KH, Lachman LB, Oppenheim JJ, Favata MF: The functional relationship of the interleukins. J Exp Med 151:1551–1556, 1980 | Article | PubMed | ISI | ChemPort |
  132. Farrar WL, Miziel SB, Farrar JJ: Participation of lymphocyte activating factor (interleukin 1) in the induction of cytotoxic T cell responses. J Immunol 124:1371–1377, 1980
  133. Wagner H, Rollinghoff M: T-T-cell interaction during in vitro cytotoxic allograft responses. I. Soluble products from activated Ly1+T cells trigger autonomously antigen–primed Ly23+ T-cells to cell proliferation and cytolytic activity. J Exp Med 148:1523–1538, 1978 | Article | PubMed | ISI | ChemPort |
  134. Baker PE, Gillis S, Ferm MM, Smith KA: The effect of T-cell growth factor on the generation of cytolytic T cells. J Immunol 121:2168–2173, 1978
  135. Gillis S, Crabtree CR, Smith KA: Glucocorticoid–induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol 123:1632–1637, 1979
  136. Stadler BM, Berenstein EH, Siraganian RP, Oppenheim JJ: Monoclonal antibody against human interleukine 2 (IL-2). J Immunol 128:1620–1624, 1981
  137. Robb RJ, Munck A, Smith KA: T cell growth factor receptors: Quantitation, specificity and biological relevance. J Exp Med 154:1455–1474, 1981 | Article | PubMed | ISI | ChemPort |
  138. Maizel AL, Mehta SR, Hauft S, Franzini D, Lachman LB, Ford RJ: Human T lymphocyte/monocyte interaction in response to lectin: Kinetics of entry into the S-phase. J Immunol 127:1058–1064, 1981
  139. Kawase I, Brooks CG, Luribayashi K, Olabuenaga S, Newman W, Gillis S, Henne CS: Interleukin 2 induces interferon production: Participation of macrophages and NK-like cells. J Immunol 131:288–292, 1983
  140. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE: Identification of a T cell-derived B cell gsrowth factor distinct from interleukin 2. J Med Exp 155:914–923, 1982
  141. Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizuk, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T: B cell growth factor (BCGF) and B cell differentiation factor (BCDF) from human T hybridoma: Two distinct kinds of BCGFs and their synergism in B cell proliferation. J Exp Med 157:583–590, 1983 | Article | PubMed | ISI | ChemPort |
  142. King DP, Jones PP: Induction of la and H-2 antigens on a macrophage cell line by immune interferon. J Immunol 131:315–318, 1983 | PubMed | ChemPort |
  143. Steeg PS, Moore RN, Johnson HM, Oppenheim JJ: Regulation of murine la antigen expression by a lymphokine with immune interferon activity. J Exp Med 156:1780–1794, 1982 | Article | PubMed | ISI | ChemPort |
  144. Krzych U, Fowler AV, Miller A, Sercarz EE: Repertoires of T cells directed against a large protein antigen, beta–gluctosidase. I. Helper cells have a more restricted specificity repertoire than proliferative cells. J Immunol 128:1529–1534, 1982
  145. Dutton RW, Eady JD: An in vitro system for the study of mechanisms of antigen stimulation in the secondary response. Immunology 7:40–53, 1964 | ISI |
  146. Smith JW, Steiner AL, Parker CW: Human lymphocyte metabolism. Effects of cyclic and monocyclic nucleotides in stimulation by phytohemagglutinin. J Clin Invest 50:442–448, 1971 | PubMed | ChemPort |
  147. Buckley PJ, Wedner HJ: Variations in DNA and RNA synthetic responses during activation of lymphocytes from inbred strains of mice. J Immunol 119:9–18, 1977
  148. Buckley PJ, Wedner HJ: Measurement of the DNA synthetic capacity of activated lymphocytes: Nucleotide triphosphate incorporation by permeabilized cells. J Immunol 120:1930–1940, 1978
  149. Betel I, Martijnse J, vander Westen G: Mitogenic activation and proliferation of mouse thymocytes. Comparison between isotope incorporation and flow microfluorometry. Exp Cell Res 124:329–337, 1979
  150. Jerne NK, Henry C, Nordin AA, Fuji H, Koros AMC, Lefkovits I: Plaque forming cells: Methodology and theory. Transplant Rev 18:130–191, 1974 | PubMed | ChemPort |
  151. Plotz PH, Talal N, Asofsky R: Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes. J Immunol 100:744–751, 1968
  152. Golub ES, Mishell RI, Weigle WO, Dutton RW: A modification of the hemolytic plaque assay for use with protein antigens. J Immunol 100:133–137, 1968 | PubMed | ChemPort |
  153. Sweet GH, Welborn FL: Use of chromium chloride as the coupling agent in a modified plaque assay. Cells producing anti-protein antibody. J Immunol 106:1407–1410, 1971
  154. Gronowicz E, Coutinho A, Melchers F: A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol 6:588–590, 1976 | PubMed | ChemPort |
  155. Beale MG, Nash GS, Bertovich MJ, MacDermott RP: Similar disturbances in B cell activity and regulatory T cell function in Henoch–Schonlein purpura and systemic lupus erythematosus. J Immunol 128:486–491, 1982 | ISI | ChemPort |
  156. Ooi BS, Ooi YM, Hsu A, Hurtubise PA: Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous nephropathy. J Clin Invest 65:789–797, 1980 | PubMed |
  157. Miyakawa Y, Kitamura K, Shibata S, Naruse T: Demonstration of human nephritogenic tubular antigen in the serum and organs by radioimmunoassay. J Immunol 117:1203–1210, 1976
  158. Sakai H, Nomoto Y, Amimori S: Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy. Clin Exp Immunol 38:243–248, 1979
  159. Asano Y, Singer A, Hodes RJ: Role of the major histocompatibility complex in T cell activation of B cell subpopulations. Major histocompatibility complex–restricted and unrestricted B cell responses are mediated by different B cell subpopulations. J Exp Med 154:1100–1115, 1981
  160. Ramila G, Studer S, Kennedy M, Sklenar I, Erb P: Evaluation of accessory cell hetergeneity. I. Differential accessory cell requirement for T helper cell activation and for T-B cooperation. Eur J Immunol 15:1–6, 1985
  161. Asano Y, Hodes RJ: T cell regulation of B cell activation I-A-restricted suppressor cells inhibit the major histocompatibility complex–restricted interactions of T helper cells with B cells and accessory cells. J Exp Med 157:1867–1884, 1983
  162. Govaerts A: Cellular antibodies in kidney homotransplantation. J Immunol 85:516–522, 1960 | PubMed | ISI | ChemPort |
  163. Perlman P, Holm G: Cytotoxic effects of lymphoid cells in vitro. Adv Immunol 11:117–193, 1969 | PubMed | ChemPort |
  164. Brunner KT, Mavel J, Cerottini JC, Chapius B: Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181–196, 1968 | PubMed | ISI | ChemPort |
  165. Canty TG, Wunderlich JR: Quantitative in vitro assay of cytotoxic cellular immunity. Journal of the National Cancer Institute 45:761–772, 1970
  166. Alter BJ, Schendel DJ, Bach ML, Bach FH, Klein J, Stimpling JH: Cell mediated lympholysis: Importance of serologically defined H-2 regions. J Exp Med 137:1303–1309, 1973 | Article | PubMed | ISI | ChemPort |
  167. Martz E: Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization. J Immunol 115:261–267, 1975
  168. Lees RK, Macdonald HR, Sinclair NR: Inhibition of clone formation as an assay for T cell mediated cytotoxicity: short term kinetics and comparison with 5lCr release. J Immunol Meth 16:233–244, 1977
  169. Sanderson CJ: The mechanism of lymphocyte mediated cytotoxicity. Biol Rev 56:153–197, 1981
  170. Wilson A, Chen W-F, Scollay R, Shortman K: Semi-automated limit–dilution assay and clonal expansion of all T-cell precursors of cytotoxic lymphocytes. J Immunol Meth 52:283–306, 1982
  171. Mullbacher A, Parish CR, Mundy JP: An improved colori-metric assay for T cell cytotoxicity in vitro. J Immunol Meth 68:205–215, 1984
  172. Zinkernagel RM, Doherty PC: H-2 compatibility requirement for T cell–mediated lysis of target cells infected with lymphocytic choriomeningitis virus Different cytotoxic T cell specificities are associated with structures coded in H-2K or H-2D. J Exp Med 141:1427–1436, 1975 | Article | PubMed | ISI | ChemPort |
  173. Neilson EG, Phillips SM: Cell–mediated immunity in interstitial nephritis II. T lymphocyte effector mechanisms in nephritic guinea pigs: Analysis of the renotropic migration and cytotoxic response. J Immunol 123:2381–2385, 1979
  174. Neilson EG, Phillips SM: Murine interstitial nephritis I. Analysis of disease susceptibility and its relationship to pleiomorphic gene products defining both immune response genes and a restrictive requirement for cytotoxic T cells at H-2K. J Exp Med 155:1075–1085, 1982 | Article | PubMed | ISI | ChemPort |
  175. Mayer TG, Fuller AA, Fuller TC, Lazarovits AI, Boyle LA, Kurnick JT: Characterization of in vivo-activated al-lospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol 134:258–264, 1985
  176. Strom TB, Tilney NL, Carpenter CB, Busch CJ: Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med 292:1257–1263, 1975 | PubMed | ISI | ChemPort |
  177. Strom TB, Tilney NL, Paradysz JM, Bancewicz J, Carpetner CB: Cellular components of allograft rejection: Identity, specificity and cytotoxic function of cells infiltrating acutely rejecting allografts. J Immunol 118:2020–2026, 1977
  178. Phillips WH, Ortaldo JR, Herberman RB: Selective depletion of human natural killer cells an monolayers of target cells. J Immunol 125:2322–2327, 1980
  179. Zakheim B, McCafferty E, Phillips SM, Clayman M, Neilson EG: Murine interstitial nephritis. II. The adoptive transfer of disease with immune T lymphocytes produces a phenotyp-ically complex interstitial lesion. J Immunol 133:234–239, 1984 | PubMed | ISI | ChemPort |
  180. Nemlander A, Saksela E, Hayry P: Are "natural killer" cells involved in allograft rejection. Eur J Immunol 13:348–351, 1983
  181. Hancock WW: Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies with monoclonal antibodies. Immunol Rev 77:61–84, 1984
  182. Neilson EG, Phillips SM: Cell mediated immunity in interstitial bnephritis IV Anti-tubular basement membrane antibodies can function in antibody–dependent cellular cytotoxicity reactions: Observations on a nephritogenic effector mechanism acting as an informational bridge between the humoral and cellular immune response. J Immunol 126:1990–1993, 1981
  183. Shin HS, Snyderman R, Friedman E, Mellors A, Mayer MM: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162:361–363, 1963
  184. Ward PA, Newman LJ: A neutrophil chemotactic factor from human C'5. J Immunol 102:93–99, 1969 | PubMed | ChemPort |
  185. Schiffman E, Corcoran BA, Wahl SM: N-formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sci USA 72:1059–62, 1975
  186. Showell HJ, Freer RJ, Zigmond SH, Schiffman E, Aswanikumar S, Corcoran B, Becker EL: Structure-activity relations of synthetic peptides as chemoattractants and inducers of lysosomal enzyme secretion for neutrophils. J Exp Med 143:1154–69, 1976 | Article | PubMed | ISI | ChemPort |
  187. Turner SR, Tainer JA, Lynn WS: Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 257:680–681, 1975 | Article | PubMed | ISI | ChemPort |
  188. Goetzl EJ, Pickett WC: The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETES). J Immunol 125:1789–1791, 1980 | PubMed | ChemPort |
  189. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH: Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265, 1980 | Article | PubMed | ChemPort |
  190. Snyderman R, Altman LC, Hausman MS, Mergenhagen SE: Human mononuclear leukocyte chemotaxis: A quantitative assay for humoral and cellular chemotactic factors. J Immunol 108:857–860, 1972 | PubMed | ChemPort |
  191. Spilberg I, Gallacher A, Mehta J, Mandell B: Urate crystal induced chemotactic factor, isolation and partial characterization. J Clin Invest 58:815–819, 1976 | PubMed | ChemPort |
  192. Koo C, Snyderman R: The oligopeptide chemoattractant receptor on human neutrophils converts to an irreversible high affinity state subsequent to agonist exposure. (abstract) Clin Res 31:491A, 1983
  193. Fletcher MP, Gallin JI: Degranulating stimuli increase the availability of receptors on human neutrophils for the chemoattractant fMet-Leu-Phe. J Immunol 124:1585–1588, 1980
  194. Koo C, Lefkowitz RJ, Snyderman R: Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. J Clin Invest 72:748–753, 1983 | PubMed | ChemPort |
  195. Gallin EK, Gallin JI: Interaction of chemotactic factors with human macrophages: induction of transmembrane potential changes. J Cell Biol 75:277–289, 1977 | Article | PubMed | ISI | ChemPort |
  196. Naccache PH, Showell HJ, Becker EL, Sha'afi RI: Transport of sodium, potassium, and calcium across rabbit polymorphonuclear leukocyte membranes: effect of chemotactic factor. J Cell Biol 73:428–444, 1977
  197. Gallin JI, Rosenthal HS: The regulatory role of divalent cations in human granulocyte chemotaxis: evidence for an association between calcium exchanges and microtubule assembly. J Cell Biol 62:594–609, 1974 | Article | PubMed | ChemPort |
  198. Hill HR: Cyclic nucleotides as modulators of leukocyte chemotaxis, in Leukocyte Chemotaxis, edited by Gallin JI, Quie PG, New York Raven Press, 1978, pp. 179–93
  199. O'Dea RF, Viveros OH, Axelrod J, Aswanikumar S, Schiffman E, Corcoran BA: Rapid stimulation of protein carboxymethylation in leukocytes by a chemotactic peptide. Nature 272:462–64, 1978 | Article |
  200. Pike MC, Kredich NM, Snyderman R: Requirement of S-adenosylmethionine–mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci USA 75:3928–3932, 1978
  201. Schiffman E: Leukocyte chemotaxis. Ann Rev Physiol 44:553–568, 1982
  202. Goetzl EJ: Role for endogenous monohydroxy-eicosatetraenoic acids (HETES) in regulation of human neutrophil migration. Immunology 40:709–19, 1980 | PubMed | ISI | ChemPort |
  203. Goldstein I, Hoffstein S, Gallin J, Weissman G: Mechanisms of lysosomal enzyme release from human leukocytes: Microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci USA 70:2916–2920, 1973 | Article | PubMed | ChemPort |
  204. Snyderman R, Pike MC: Chemoattractant receptors on phagocytic cells. Ann Rev Immunol 2:257–281, 1984
  205. Wilkinson PC: The measurement of leukocyte chemotaxis. J Imunol Meth 51:133–148, 1982
  206. Zigmond SH: The ability of polymorphonuclear cells to orient in gradients of chemotactic factors. J Cell Biol 75:606–616, 1977 | Article | PubMed | ISI | ChemPort |
  207. Boyden S: The chemotactic effects of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 115:453–466, 1962 | Article | PubMed | ISI | ChemPort |
  208. Falk W, Goodwin RH, Leonard EJ: A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Meth 33:239–247, 1980 | Article | ISI | ChemPort |
  209. Zigmond SH, Hirsch JG: Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of cell–derived chemotactic factor. J Exp Med 137:387–410, 1973 | Article | PubMed | ISI | ChemPort |
  210. Cutler JE: A simple in vitro method for studies on chemotaxis (38367). Proc Soc Exp Biol Med 147:471–474, 1974 | PubMed | ISI | ChemPort |
  211. Kennedy TL, Merrow M, Phillips SM, Norman M, Neilson EG: Mononuclear cell chemotaxis in anti-trubular basement membrane induced interstitial nephritis in guinea pigs. Clin Immunol Immunopathol 1985 (in press)
  212. Norman ME, Mandle R, Nilsson UR: Further studies of a humoral chemotactic abnormality in glomerulonephritis. Int Archs Allergy Appl Immunol 56:144–154, 1978
  213. Landsteiner K, Chase MW: Experiments on transfer of cutaneous sensitivity to simple chemical compounds. Proc Soc Exp Biol 49:688–690, 1942
  214. Crowle AJ: Delayed hypersensitivity in mice: Its detection by skin tests and its passive transfer. Science 130:159–160, 1959
  215. Crowle AJ: Tuberculin skin reactions in mice hypersensitized by vaccination with living avirulent tubercle bacilli. Am Rev Resp Dis 81:893–903, 1960
  216. Platt JL, Grant BW, Eddy A, Michael AF: Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med 158:1227–1242, 1983 | Article | PubMed | ChemPort |
  217. Scheynius AL, Kareskog L, Forsum U: In situ identification of T lymphocytes subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol 49:325–330, 1982 | PubMed | ChemPort |
  218. Vadas MA, Miller JFAP, McKenzie IFC, Chism SE, Shen F-W, Boyse EA, Gamble JR, Whitelaw AM: Ly and la antigen phenotypes of T cells involved in delayed type hypersensitivity and in suppression. J Exp Med 144:10–19, 1976 | Article | PubMed | ChemPort |
  219. Ertl HCJ: Adoptive transfer of delayed type hypersensitivity to sendai virus. I. Induction of two different subsets of T lymphocytes which differ in H-2 restriction as well as in the Lyt phenotype. Cell Immunol 62:38–49, 1981
  220. Asherson GL, Zembala M: Contact sensitivity in the mouse. IV. The role of lymphocytes and macrophages in passive transfer and the mechanism of their interaction. J Exp Med 132:1–15, 1970 | Article | PubMed | ChemPort |
  221. Van Loveren H, Askenase PW: Delayed–type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol 133:2397–2401, 1984 | PubMed | ChemPort |
  222. Crowle AJ: Delayed hypersensitivity in the mouse. Adv Immunol 20:197–264, 1975 | PubMed | ChemPort |
  223. Crowle AJ, Hu CC: Studies on the induction and time course of repression of delayed hypersensitivity in the mouse by low and high doses of antigen. Clin Exp Immunol 6:363–374, 1970
  224. Kong Y-CM, Savage DC, Kong LNL: Delayed dermal hypersensitivity in mice to spherule and mycelial extracts of coccid-ioides immitus. J Bacterial 91:876–883, 1966
  225. Neilson EG, McCafferty E, Mann R, Michaud L, Clayman M: Murine interstitial nephritis. III. The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2K characterizes the cell–mediated potential for disease expression: susceptible mice provide a unique effector T cell repertoire in response to tubular antigen. J Immunol 134:2375–2382, 1985
  226. Vadas MA, Miller JFAP, Gamble J, Whitelaw A: A radioisotope method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allerg Appl Immunol 49:670–692, 1975 | ChemPort |
  227. Selbie FR, O'Grady F: A measurable tuberculous lesion in the thigh of the mouse. Br J Exp Path 35:556–565, 1954
  228. Gray DF, Jennings PA: Allergy in experimental mouse tuberculosis. Am Rev Tuherc 72:171–195, 1955
  229. Youdim S, Stutman O, Good RA: Studies of delayed hypersensitivity to L. monocytogens in mice: nature of cells involved in passive transfers. Cell Immunol 6:98–109, 1973
  230. Uyeki EM, Klassen RS, Llacer V: Analysis of dextran- and methylated albumin-induced hypersensitivity by mouse paw swelling. Proc Soc Exp Biol Med 132:1140–1146, 1969
  231. Pearson LD, Osebold JW, Wagner PC: A device for measuring the volume of footpad swelling from delayed hypersensitivity reactions in mice. Lab Anim Sci 21:591–593, 1971
  232. Sunday ME, Benacerraf B, Dorf ME: Hapten–specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. VI. Evidence for different T cell receptors in cells that mediate H-2I-restricted and H-2D-restricted cutaneous sensitivity responses. J Exp Med 152:1554–1562, 1980 | Article | PubMed | ChemPort |
  233. Miller JFAP, Vadas MA, Whitlaw A, Gamble J: Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci USA 73:2486–2490, 1976 | Article | PubMed | ChemPort |
  234. Lehman DH, Wilson CB: Role of sensitized cells in anti-tubular basement interstitial nephritis. Int Arch Allergy Appl Immunol 51:168–174, 1976
  235. Von Boehmer, Hudson L, Sprent J: Collaboration of histoin-compatible T and B lymphocytes using cells from tetraparental bone marrow chimeras. J Exp Med 142:989–997, 1975
  236. Zinkernagel RM: H-2 restriction of virus–specific cytotoxicity across the H-2 barrier: Separate effector T cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras. J Exp Med 144:933–945, 1976 | Article | PubMed | ChemPort |
  237. Sprent J, Von Boehmer H: T-helper function of parent right arrow F1 chimeras: presence of a separate T-cell subgroup able to stimulate allogeneic B cells but not syngeneic B cells. J Exp Med 149:387–397, 1979
  238. Groves ES, Singer A: Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens. J Exp Med 158:1483–1497, 1983 | Article | PubMed | ISI | ChemPort |
  239. Matzinger P, Zamoyska R, Waldmann H: Self tolerance is H-2 restricted. Nature 308:738–741, 1984 | Article | PubMed | ISI | ChemPort |
  240. Neilson EG, McCafferty E, Feldman A, Clayman MD, Zakheim B, Korngold R: Spontaneous interstitial nephritis in kdkd mice. I. An experimental model of autoimmune renal disease. J Immunol 133:2560–2565, 1984 | PubMed | ISI | ChemPort |
  241. Mampaso FM, Wilson CB: Characterization of inflammatory cells in autoimmune interstitial nephritis in rats. Kidney Int 23:448–457, 1983 | PubMed | ISI | ChemPort |
  242. Franklin WA, Locker JD: Ethidium bromide: A nucleic acid stain for tissue sections. J Histochem Cytochem 29:572–576, 1981 | PubMed | ChemPort |
  243. Johnson GD, Araujo GMCN: A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Meth 43:349–350, 1981 | Article | ChemPort |
  244. Platt JL, Michael AF: Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem 31:840–842, 1983 | PubMed | ISI | ChemPort |
  245. Platt JL, LeBien TW, Michael AF: Interstitial mononuclear cell populations in renal graft rejection: Identification by monoclonal antibodies in tissue sections. J Exp Med 155:17–30, 1982 | Article | PubMed | ISI | ChemPort |
  246. Zakheim B, McCafferty E, Phillips SM, Clayman M, Neilson EG: Murine interstitial nephritis. II. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J Immunol 133:234–239, 1984 | PubMed | ISI | ChemPort |
  247. Atkins RC, Holdsworth SR, Hancock WW, Thomson NM, Glasgow EF: Cellular immune mechanisms in human glomerulonephritis: The role to mononuclear leukocytes. Springer Se min Immunopathol 5:221–249, 1982
  248. Daily MD, Gallatin WM, Weissman IL: The in vivo behavior of T cell clones: Altered migration due to loss of the lymphocyte surface homing receptor. J Mol Cell Immunol 2:27–36, 1985
  249. Basch RS, Berman JW, Lakwo E: Cell separation using positive immunoselective techniques. J Immunol Meth 56:269–280, 1983
  250. Stenglein B, Thoenes GH, Gunther E: Genetic control of susceptibility to autologous immune complex glomerulonephritis in inbred rat strains. Clin Exp Immunol 33:88–94, 1978
  251. Sapin C, Mandet C, Druet E, Gunther E, Druet P: Immune complex type disease induced by HgCL in Brown–Norway rats: Genetic control of susceptibility. Clin Exp Immunol 48:700–704, 1982
  252. Neilson EG, Gasser DL, McCafferty E, Zakheim B, Phillips SM: Polymorphism of genes involved in anti-tubular basement membrane disease in rats. Immunogenetics 17:55–65, 1983
  253. Matsumoto K, McCafferty E, Neilson EG, Gasser D: Mapping of the genes for tubular basement membrane antigen and a submaxillary gland protose in the rat. Immunogenetics 20:117–123, 1984
  254. Rees AJ: The HLA complex and susceptibility to glomerulonephritis. Plasma Therpy 5:455–470, 1984
  255. Bolton WK, Benton FR, Lobo PI: Requirement of functional T cells in the production of autoimmune glomerulotubular nephropathy in mice. Clin Exp Immunol 33:474–477, 1978 | PubMed |
  256. Cantor H, Gershon RK: Immunological circuits: Cellular composition. Fed Proc 38:2058–2064, 1979 | PubMed | ISI | ChemPort |
  257. Kappler JW, Marrack P: The role of H-2 linked genes in helper T cell function. IV. Importance of T cell genotype and host environment in I region and Ir gene expression. J Exp Med 148:1510–1522, 1978 | Article | PubMed | ISI | ChemPort |
  258. Longo DL, Matis LA, Schwartz RH: Insights into immune response gene function from experiments with chimeric animals. CRC Crit Rev Immunol 2:83–110, 1981
  259. Miller JFAP, Gamble J, Mottram P, Smith FI: Influence of thymus genotype on acquisition of responsiveness in delayed-type hypersensitivity. Scand J Immunol 9:29–38, 1979
  260. Weigle WO: Analysis of autoimmunity through experimental models of thyroiditis and allegic encephalomyelitis. Adv Immunol 30:159–273, 1980 | PubMed | ChemPort |
  261. Waksman BH: Adjuvants and immune regulation by lymphoid cells. Springer Semin Immunopathol 2:5–33, 1979
  262. Nossal GJV: Cellular mechanisms of immunologic tolerance. Ann Rev Immunol 1:33–62, 1983
  263. Janeway CA: Immune response genes the problem of the non-responder. J Mol Cell Immunol 1:15–18, 1983
  264. Fathman CG, Frelinger JG: T-lymphocytes clones. Ann Rev Immunol 1:633–656, 1983
  265. Heber–Katz E, Hansburg D, Schwartz RH: The la molecule of the antigen–presenting cell plays a critical role in immune response gene regulation of T cell activation. J Mol Cell Immunol 1:3–14, 1983 | PubMed | ChemPort |
  266. Bernard CCA, Leydon J, Mackay IR: T cell necessity in the pathogenesis of experimental autoimmune encephalomyelitis in mice. Eur J Immunol 6:655–660, 1976 | PubMed | ISI | ChemPort |
  267. Ortiz–Ortiz L, Weigle WO: Cellular events in the induction of experimental allergic encephalomyelitis in rats. J Exp Med 144:604–616, 1976 | Article | PubMed | ChemPort |
  268. Simon MM, Abenhardt B: Generation of effector cells from T cell subsets II. Lyt 123 T cells contain the precursors for all primary cytotoxic effector cells and for cells involved in the regulation of cytotoxic responses. Eur J Immunol 10:334–341, 1980
  269. Pilarski L: A requirement for antigen–specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors. J Exp Med 145:709–725, 1977 | Article | PubMed | ISI | ChemPort |
  270. Asano Y, Hodes RJ: T cell regulation of B cell activation MHC-restricted T augmenting cells enhance the B cell responses mediated by MHC-restricted cloned T helper cells. J Immunol 132:1151–1157, 1984
  271. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T: Organ–specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self–tolerance; deficit of a T cell subset as a possible course of autoimmune disease. J Exp Med 161:72–87, 1985 | Article | PubMed | ISI | ChemPort |
  272. Holffsten PE, Villalobos R, Hill C, Klahr S: T cell deficiency in immune complex glomerulonephritis. Kidney Int 11:318–326, 1977
  273. Greene MI, Ratnofsky S, Takaoki M, Sy MS, Burakoff S, Finberg RW: Antigen–specific suppression of cytotoxic T cell responses: An idiotype–bearing factor regulates the cytotoxic T cell response to azobenzene arsonate–coupled cells. J Immunol 128:1188–1191, 1982
  274. Susskind BM, Merluzzi J, Faanes RB, Palladino A, Choi YS: Regulatory mechanisms in cytotoxic T lymphocyte development. I. A suppressor T cell subset that regulates the proliferative stage of CTL development. J Immunol 130:527–532, 1983
  275. Kelly CJ, Clayman MD, Neilson EG: Immunoregulation in experimental interstitial nephritis: Immunization with renal tubular antigen in incomplete Freund's adjuvant induces major histocompatability complex (RTI)-restricted, 0 times 8+ suppressor T cells which are antigen–specific and inhibit the expression of disease. J Immunol 136:903–907, 1986 | PubMed |
  276. Chandra M, Tyson T, Sturgill B, Bolton K: Transfer of experimental autoimmune glomerulonephritis in chickens by sensitized cells. (abstract) Kidney Int 27:208A, 1985
  277. Holda JH, Welch AM, Swanborg RH: Autoimmune effector cells. I. Transfer of experimental allergic encephelitis with lymphoid cells cultured with antigen. Eur J Immunol 10:657–659, 1980
  278. Bhan AK, Schneeberger E, Collins A, McCluskey RT: Evidence for a pathogenic role of cell–mediated immune mechanism in experimental glomerulonephritis. J Exp Med 148:246–260, 1978 | Article | PubMed | ISI | ChemPort |
  279. Unanue ER, Schriener GF, Cotran RS: A role of mononuclear phagocytes in immunologically induced glomerulonephritis, in Immune Mechanisms of Renal Disease, edited by Michael A, Cummings N, Wilson CB, New York, Plenum Press, 1983, pp. 443–151
  280. Wadygmar A, Urmson J, Baumal R, Halloran PF: Changes in la expression in mouse kidney during acute graft-vs-host disease. J Immunol 132:1826–1832, 1984
  281. Holm G: In vitro cytotoxic effects of lymphoid cells from rats with experimental autoimmune nephrosis. Clin Exp Immunol 1:45–60, 1966
  282. Striker GE, Mannik N, Tung MY: Role of marrow–derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med 149:127–136, 1979 | Article | PubMed | ChemPort |
  283. Lavell KJ, Durland BD, Yum MN: The effect of anti-macrophage antiserum on immune complex glomerulonephritis. J Lab Clin Med 98:195–205, 1981
  284. Holdsworth SR, Neale TJ, Wilson CB: Abrogation of macrophage–dependent injury in experimental glomerulonephritis in the rabbit. J Clin Invest 68:686–698, 1981 | PubMed | ISI | ChemPort |
  285. Holdsworth SR: Fc dependence of macrophage accumulation and subsequent injury in experimental glomerulonephritis. J Immunol 130:735–739, 1983 | PubMed |

Extra navigation

.
ADVERTISEMENT